CytoMed Therapeutics Announces Board Re-organization
Ticker: GDTC · Form: 6-K · Filed: Jun 20, 2024 · CIK: 1873093
| Field | Detail |
|---|---|
| Company | Cytomed Therapeutics LTD (GDTC) |
| Form Type | 6-K |
| Filed Date | Jun 20, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: governance, board-of-directors, regulatory-filing
TL;DR
CytoMed Therapeutics is shuffling its board as per its constitution.
AI Summary
CytoMed Therapeutics Ltd. filed a Form 6-K on June 20, 2024, reporting a board re-organization. This action is in accordance with Regulation 117 of the Company's Constitution, which mandates the rotation of one-third of the Board of Directors.
Why It Matters
Board re-organizations can signal changes in company strategy or governance, potentially impacting investor confidence and future operational direction.
Risk Assessment
Risk Level: low — The filing is a routine procedural update regarding board composition and does not indicate significant financial or operational changes.
Key Players & Entities
- CytoMed Therapeutics Ltd. (company) — Registrant
- June 20, 2024 (date) — Filing Date
- Regulation 117 (regulation) — Governing Board Rotation
FAQ
What is the specific reason for the board re-organization at CytoMed Therapeutics Ltd.?
The board re-organization is a mandatory action required by Regulation 117 of the Company's Constitution, which stipulates the rotation of one-third of the Board of Directors.
When was this Form 6-K filed with the SEC?
This Form 6-K was filed on June 20, 2024.
Does this filing indicate any changes to CytoMed Therapeutics' financial status?
No, this filing specifically pertains to a board re-organization and does not contain information about the company's financial status.
What is the principal executive office address for CytoMed Therapeutics?
The principal executive office is located at 1 Commonwealth Lane #08-22, Singapore 149544.
Is CytoMed Therapeutics required to file annual reports on Form 20-F or 40-F?
Yes, CytoMed Therapeutics is indicated to file annual reports under cover of Form 20-F.
Filing Stats: 362 words · 1 min read · ~1 pages · Grade level 12.2 · Accepted 2024-06-20 13:50:27
Filing Documents
- form6-k.htm (6-K) — 17KB
- 0001493152-24-024464.txt ( ) — 18KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities and Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. CytoMed Therapeutics Limited Date: June 20, 2024 By: /s/ CHOO Chee Kong CHOO Chee Kong Director and Chairman